|
|
|
Volumn 38, Issue 1, 2013, Pages 13-16
|
|
Pharmaceutical Approval Update
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTIVATED CARBON;
BETA INTERFERON;
COLESTYRAMINE;
CYTOCHROME P450 3A4;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
FLUCONAZOLE;
GLATIRAMER;
KETOCONAZOLE;
LEFLUNOMIDE;
METHOTREXATE;
PERAMPANEL;
PLACEBO;
RIFAMPICIN;
TERIFLUNOMIDE;
TOFACITINIB;
ACUTE KIDNEY FAILURE;
ANGER;
ANXIETY;
BEDTIME DOSAGE;
BLOOD CELL COUNT;
BONE MARROW DISEASE;
CELLULITIS;
DIARRHEA;
DRUG APPROVAL;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG WITHDRAWAL;
HEADACHE;
HERPES ZOSTER;
HOSTILITY;
HUMAN;
HYPERKALEMIA;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
IRRITABILITY;
KIDNEY DISEASE;
LIVER DISEASE;
LIVER FAILURE;
LIVER INJURY;
LIVER TOXICITY;
LYMPHOPROLIFERATIVE DISEASE;
MOOD CHANGE;
MULTIPLE SCLEROSIS;
NEOPLASM;
NOTE;
PERIPHERAL NEUROPATHY;
PHARYNGITIS;
PHARYNX DISEASE;
PHASE 3 CLINICAL TRIAL (TOPIC);
PREGNANCY;
RECOMMENDED DRUG DOSE;
RESPIRATORY TRACT DISEASE;
RHEUMATOID ARTHRITIS;
RISK FACTOR;
SEIZURE;
SIDE EFFECT;
STEVENS JOHNSON SYNDROME;
SUICIDAL IDEATION;
TERATOGENICITY;
TOXIC EPIDERMAL NECROLYSIS;
TUBERCULOSIS;
UPPER RESPIRATORY TRACT INFECTION;
URINARY TRACT INFECTION;
VACCINATION;
|
|
EID: 84872712827
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
